首页> Blood> Analysis of 153 115 patients with hematological malignancies refines the spectrum of familial risk.

Analysis of 153 115 patients with hematological malignancies refines the spectrum of familial risk.

导出 OA

翻译打印收藏纠错

第一作者： Amit,Sud

第一单位： Division of Genetics and Epidemiology, The Institute of Cancer Research, London, United Kingdom.;Division of Molecular Genetic Epidemiology, German Cancer Research Centre, Heidelberg, Germany.

作者： Amit,Sud ^[1] ; Subhayan,Chattopadhyay ^[2] ; Hauke,Thomsen ^[3] ; Kristina,Sundquist ^[4] ; Jan,Sundquist ^[4] ; Richard S,Houlston ^[5] ; Kari,Hemminki ^[6]

作者单位： Division of Genetics and Epidemiology, The Institute of Cancer Research, London, United Kingdom.;Division of Molecular Genetic Epidemiology, German Cancer Research Centre, Heidelberg, Germany. ^[1] Division of Molecular Genetic Epidemiology, German Cancer Research Centre, Heidelberg, Germany.;Faculty of Medicine, University of Heidelberg, Heidelberg, Germany. ^[2] Division of Molecular Genetic Epidemiology, German Cancer Research Centre, Heidelberg, Germany. ^[3] Center for Primary Health Care Research, Lund University, Malmö, Sweden.;Department of Family Medicine and Community Health, Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, NY.;Center for Community-based Healthcare Research and Education, Department of Functional Pathology, School of Medicine, Shimane University, Matsue, Japan; and. ^[4] Division of Genetics and Epidemiology, The Institute of Cancer Research, London, United Kingdom.;Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom. ^[5] Division of Molecular Genetic Epidemiology, German Cancer Research Centre, Heidelberg, Germany.;Center for Primary Health Care Research, Lund University, Malmö, Sweden. ^[6]